Virtual Medicinal Product (VMP) - Testosterone 16.2mg/g transdermal gel (20.25mg per actuation)

Navigation

Name Details

Name Start Date End Date
Name Current Name Testosterone 16.2mg/g transdermal gel (20.25mg per actuation) Start Date 01-11-2023 End Date
Previous Name Previous Name Testosterone 16.2mg/g gel (20.25mg per actuation) Start Date 22-12-2017 End Date 31-10-2023
Abbreviated Name Abbreviated Name Testosterone 16.2mg/g gel (20.25mg per actuation) Start Date 01-11-2023

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.25
UDFS UOM
gram
Unit Dose UOM
actuation

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
Schedule 4 (CD Anab)
Route
Transdermal
Form
Transdermal gel
Ontology Form/Route
gel.transdermal
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
G03BA03
BNF Codes
  • BNF code 06040200
SNOMED Codes
Code Start Date End Date
35025711000001101 22-12-2017

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Testosterone Based on Ingredient Substance 16.2 mg 1 gram

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
88 gram 3994 Part VIIIA Category C